FKBP1A and neoplasm: Liu et al. demonstrated that the FKBP12 protein promotes the degradation of the oncogenic protein MDM2 through self-ubiquitination, favoring the efficiency of doxorubicin treatment in tumor lines of neuroblastoma [44].